NATALIE EISENHOWER: Open Payments
NPI 1942644786 · MARLTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$460 in 15 payments from 6 companies in 2025. Trend: 2023 $265 · 2024 $42 · 2025 $460
Food & beverage: $348Education: $111
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $182 |
| Teva Pharmaceuticals USA, Inc. | 1 | $111 |
| Neurocrine BioSciences, Inc. | 3 | $65 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $38 |
| E.R. Squibb & Sons, L.L.C. | 2 | $34 |
| Lundbeck LLC | 2 | $30 |
Products named: REXULTI, INGREZZA, ABILIFY ASIMTUFII, CAPLYTA, COBENFY.
Industry payments across NJ — which companies pay providers there.
